64 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
7
New dermatological agents for the treatment of psoriasis.

Allergan
4
Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agent.

Allergan
7
Synthesis and biological activity of retinoic acid receptor-alpha specific amides.

Allergan
4
Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.

Allergan
9
Phenylcyclohexene and phenylcyclohexadiene substituted compounds having retinoid antagonist activity.

Allergan
6
A new class of potent RAR antagonists: dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids.

Allergan
4
Stereoselective synthesis and receptor activity of conformationally defined retinoid X receptor selective ligands.

Allergan
16
High affinity retinoic acid receptor antagonists: analogs of AGN 193109.

Allergan
14
Synthesis and evaluation of 2-(arylamino)imidazoles as alpha 2-adrenergic agonists.

Allergan
4
Identification of retinoic acid receptor beta subtype specific agonists.

Allergan
8
Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid.

Allergan
5
Synthesis and evaluation of 2-[(5-methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a potent, peripherally acting alpha 2 adrenoceptor agonist.

Allergan
5
Identification of a retinoic acid receptor alpha subtype specific agonist.

Allergan
15
Synthesis and carbonic anhydrase inhibitory activity of 4-substituted 2-thiophenesulfonamides.

Allergan
10
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.

Allergan
2
Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors.

Allergan
6
Identification of highly potent retinoic acid receptor alpha-selective antagonists.

Allergan
2
Conformational control in structure-based drug design.

Allergan
247
Human plasma kallikrein inhibitors

Biocryst Pharmaceuticals
502
GCN2 inhibitors and uses thereof

Merck Patent
59
Sulfuryl-substituted benzoheterocyclic derivative, preparation method and medical use thereof

Shanghai Haiyan Pharmaceutical Technology
21
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure

Yeda Research and Development
68
Heterocyclic compounds as immunomodulators

Incyte
99
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

University Of Texas
12
3,4-alkoxy Substituted Phenethyl Lactam Compound, Preparation Method therefor, and Use Thereof

Guangzhou Chia Tai Innovative Pharmaceutical
113
Cyclopropanamine compound and use thereof

Takeda Pharmaceutical
2
α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

Merck Serono
3
Conferin, potent antioxidant and anti-inflammatory isoflavone from Caragana conferta Benth.

University of Karachi
3
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1.

National Institutes of Health
50
COMPOUND FOR INHIBITING IRAK4 ACTIVITY AND USE THEREOF

Shenzhen Zhongge Biological Technology
25
Compositions and methods of inhibiting N-acylethanolamine-hydrolyzing acid amidase

University of California
45
Heteroaromatic methyl cyclic amine derivative

Taisho Pharmaceutical
176
Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators

Roche Palo Alto
3
Structure-based virtual screening toward the discovery of novel inhibitors of the DNA repair activity of the human apurinic/apyrimidinic endonuclease 1.

Universidade De Lisboa
15
Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-Lipoxygenase.

University of California Santa Cruz
11
Pyridyl aminopyridines as Syk inhibitors

Merck Sharp & Dohme
15
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

Bristol Myers Squibb
73
Substituted benzimidazole-type piperidine compounds and uses thereof

Purdue Pharma
15
Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient

Fm Therapeutics
4
n-Alkylboronic acid inhibitors reveal determinants of ligand specificity in the quorum-quenching and siderophore biosynthetic enzyme PvdQ.

The University of Texas
21
Hydroxybenzaldoximes Are D-GAP-Competitive Inhibitors of E. coli 1-Deoxy-D-Xylulose-5-Phosphate Synthase.

The Johns Hopkins University School of Medicine
3
Compounds and method for treatment of HIV

Critical Outcome Technologies
46
Aminopyrimidine derivatives as LRRK2 modulators

Genentech
350
Heteroaryl compounds and their uses

Novartis
10
Scriptaid isosteres and their use in therapy

Karus Therapeutics
12
HDAC inhibitors and therapeutic methods of using same

University of Illinois
23
Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors

N30 Pharmaceuticals
4
2,5-disubstituted piperidine orexin receptor antagonists

Merck Sharp & Dohme
64
NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME

Checkmate Therapeutics
67
Carboxy isatin hydrazones and their esters as Shp2 inhibitors

H. Lee Moffitt Cancer Center and Research Institute
15
Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.

Ewha Womans University
14
Bacterial thioredoxin reductase inhibitors and methods for use thereof

Thioredoxin Systems
18
Imidazopyridines and imidazopyrimidines as HIV-1 reverse transcriptase inhibitors

CSIR, Pretoria (Za)
5
Design and synthesis of new 2-aryl, 3-benzyl- (1,3-oxazolidine or 1,3-thiazolidine)-4-ones as selective cyclooxygenase (COX-2) inhibitor

Shahid Beheshti University
15
Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.

North-West University
7
Lipoxygenase inhibiting and antioxidant iridoids from Buddleja crispa.

Chinese Academy of Medical Sciences
2
The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.

Preclinical R & D, Astra Arcus
7
Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI.

Institut Des BiomolÉCules Max Mousseron (Ibmm)
5
Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor.

University of Heidelberg
128
AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS

Incyte